APAC IPOs & Placements, Aequitas Research

Clarence Chu

APAC IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Sahajanand Medical Technologies Ltd / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/sahajanand-medical-technologies-ltd" target="_blank" data-smartkarma-citation="entities:35324:1" rel="noopener">Sahajanand Medical Technologies Ltd (544309Z IN)</a> is looking to raise US$202m in its upcoming India IPO. The deal will be run by Axis Capital, Bank of America, Edelweiss and UBS.</li>
<li>Sahajanand Medical Technologies is a medical devices company that researches, designs, develops, manufactures and markets vascular devices.</li>
<li>The product portfolio is led by its flagship coronary stent, Supraflex Cruz, where the product had been implanted in over 400,000 patients globally as of Mar 2021.</li>
</ul>



Sahajanand Medical Technologies Ltd (544309Z IN) is looking to raise US$202m in its upcoming India IPO. The deal will be run by Axis Capital, Bank of America, Edelweiss and UBS.
Sahajanand Medical Technologies is a medical devices company that researches, designs, develops, manufactures and markets vascular devices.
The product portfolio is led by its flagship coronary stent, Supraflex Cruz, where the product had been implanted in over 400,000 patients globally as of Mar 2021.


Sahajanand Medical Technologies Pre-IPO Tearsheet

Five Star Business Finance / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/five-star-business" target="_blank" data-smartkarma-citation="entities:35238:1" rel="noopener">Five Star Business (0958461D IN)</a> is looking to raise around US$370m in its upcoming India IPO. The deal will be run by ICICI Securities, Edelweiss, Kotak, and Nomura.</li>
<li>Five Star Business is a non-banking financial company (NBFC-ND-SI) that provides secured business loans to micro-entrepreneurs and self-employed individuals. </li>
<li>As of Sept 2021, the firm had a network of 268 branches, spread across approximately 126 districts, eight states and one union territory.  </li>
</ul>



Five Star Business (0958461D IN) is looking to raise around US$370m in its upcoming India IPO. The deal will be run by ICICI Securities, Edelweiss, Kotak, and Nomura.
Five Star Business is a non-banking financial company (NBFC-ND-SI) that provides secured business loans to micro-entrepreneurs and self-employed individuals. 
As of Sept 2021, the firm had a network of 268 branches, spread across approximately 126 districts, eight states and one union territory.  


India

Five-Star Business Finance Limited operates as a financial company. The Company provides small business and mortgage loans to eligible borrowers to meet their business and personal needs. Five-Star Business Finance serves customers in India.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Five Star Business Finance (FIVESTAR IN)

Sahajanand Medical Technologies Pre-IPO Tearsheet

Sahajanand Medical Technologies Ltd (544309Z IN) is looking to raise US$202m in its upcoming India IPO. The deal will be run by Axis Capital, Bank...

Clarence Chu

Five Star Business Pre-IPO Tearsheet

Five Star Business (0958461D IN) is looking to raise around US$370m in its upcoming India IPO. The deal will be run by ICICI Securities, Edelweiss,...

Clarence Chu

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)